Gene · 574506
Papers1,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Icaritin inhibits osteoclast differentiation and reduces bone loss by targeting ESR1 to inhibit miR503/RANK pathway. | Front Pharmacol | 2025 | 41019997 | PubTator, text mining | PubMed |
| Integrative analysis of mRNA, lncRNA, circRNA, and miRNA to investigate the anti-fibrotic activity of silibinin in TGF-β2-treated human trabecular meshwork cells. | BMC Genomics | 2025 | 40999359 | PubTator, text mining | PubMed |
| Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma. | Discov Oncol | 2025 | 40892177 | PubTator, text mining | PubMed |
| The Role of the TIMP1/LINC01615 Axis as a Regulator of the EMT Pathway in Gastric Cancer. | Biol Proced Online | 2025 | 40826020 | PubTator, text mining | PubMed |
| Prognostic value of LncRNA DLGAP1-AS2 in bladder cancer and its regulatory effect on tumor progression. | Discov Oncol | 2025 | 40824355 | PubTator, text mining | PubMed |
| Targeting Cis-regulatory elements for CRISPR-mediated transcriptional activation of the human MIR503HG locus. | Vascul Pharmacol | 2025 | 40653285 | PubTator, text mining | PubMed |
| Macrophage-driven exosomes regulate the progression of cardiovascular disease. | Front Pharmacol | 2025 | 40371346 | PubTator, text mining | PubMed |
| Endocrine-exocrine miR-503-322 drives aging-associated pancreatitis via targeting MKNK1 in acinar cells. | Nat Commun | 2025 | 40097383 | PubTator, text mining | PubMed |
| Loss of miR-424 and miR-503 promotes decidualization of human endometrial stromal cells by increasing SCARA5 expression. | Med Mol Morphol | 2025 | 40085209 | PubTator, text mining | PubMed |
| The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells. | Cell Div | 2025 | 40055797 | PubTator, text mining | PubMed |
| miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma. | J Exp Clin Cancer Res | 2025 | 39984959 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer. | Int J Mol Sci | 2025 | 39940987 | PubTator, text mining | PubMed |
| Therapeutic potential of SMAD7 targeting miRNA in the pathogenesis of diabetic nephropathy. | Arch Biochem Biophys | 2025 | 39667550 | PubTator, text mining | PubMed |
| Integrating multiomics sequencing analyses uncover the key mechanisms related to oxidative stress, mitochondria, and immune cells in keloid. | Gene | 2025 | 39489224 | PubTator, text mining | PubMed |
| Profiling mRNA and miRNA expression variations associated with cyclin-dependent kinase pathway in the low-grade luminal early breast cancer. | J Appl Genet | 2025 | 39373948 | PubTator, text mining | PubMed |
| MiRNAs and Neutrophil-Related Membrane Proteins from Plasma-Derived Extracellular Vesicles for Early Prediction of Organ Dysfunction and Prognosis in Septic Patients. | J Inflamm Res | 2024 | 39649421 | PubTator, text mining | PubMed |
| Exosomes to exosome-functionalized scaffolds: a novel approach to stimulate bone regeneration. | Stem Cell Res Ther | 2024 | 39521993 | PubTator, text mining | PubMed |
| MicroRNA-503 Suppresses Oral Mucosal Fibroblast Differentiation by Regulating RAS/RAF/MEK/ERK Signaling Pathway. | Biomolecules | 2024 | 39456192 | PubTator, text mining | PubMed |
| The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review. | Biomed Res Int | 2024 | 39445208 | PubTator, text mining | PubMed |
| Lymph node metastasis determined miRNAs in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2024 | 39401765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574506/papers?page=2